Hyman, David

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hyman, David's trades of Medicenna Therapeutics Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
283.93
Quantity 71,842 +33.9%
Value CA$1,439,380
Transaction date
Purchase
Price
352.04
Quantity 2,691 +42.8%
Value CA$3,892,462
Transaction date
Purchase
Price
338.38
Quantity 84,377 +33.1%
Value CA$509,792
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-15 2025-12-12
B Purchase
71,842 +33.9%
283.93
CA$1,439,380 		71,842 +33.9% 283.93 CA$1,439,380
2023-01-19 2023-01-18
B Purchase
2,691 +42.8%
352.04
CA$3,892,462 		2,691 +42.8% 352.04 CA$3,892,462
2022-10-19 2022-10-18
B Purchase
84,377 +33.1%
338.38
CA$509,792 		84,377 +33.1% 338.38 CA$509,792